National Mobile Asthma Management System-E Project

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

870 participants

Study Classification

INTERVENTIONAL

Study Start Date

2017-03-25

Study Completion Date

2019-06-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Bronchial asthma is a heterogeneous disease characterized by chronic airway inflammation, which is a common and frequently occurring disease in the world, and has resulted in a sustained increase of social and economic burden. However, several studies suggest, lots of asthma patients did not get their asthma controlled. The investigators study showed that in China only 28.7% of asthma patients achieve asthma controlled during 2007-2008. In recent years, application softwares of mobile-phones for asthma have gradually increased, studies suggested that application of these application softwares can make treatment more standard, reduce asthma attacks, help patients to control their asthma, improve adherence and these application softwares also show many other advantages. This study is a prospective, multi center, randomized, controlled study, aims to evaluate the efficacy of application softwares in asthma patients, provide a new tool to asthma management.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

The Study About the Identification of Treatable Traits of Severe Asthma and the Construction of Personalized Treatment System

NCT07136025

Asthma

RECRUITING NA

Efficacy of Mobile Phone Short Message Service (SMS) Reminder and Consultation on Asthma Control

NCT02189616

Asthma

UNKNOWN NA

Effect of Bronchial Thermoplasty on Moderate Bronchial Asthma in China

NCT02965807

Moderate Asthma

UNKNOWN PHASE1/PHASE2

Self-Management Using Smartphone Application for Chronic Disease Care in Real siTuation (SMART-Asthma): Adult

NCT01918293

BRONCHIAL ASTHMA

COMPLETED NA

Intervention to Improve Inhalative Adherence

NCT02386722

Chronic Asthma COPD

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Asthma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

mobile management

use mobile management to improve asthma control

Group Type EXPERIMENTAL

Mobile Asthma Management System

Intervention Type BEHAVIORAL

Patients in this group use a smartphone app in their asthma self-management.

Traditional management

use Traditional management to improve asthma control

Group Type OTHER

traditional Asthma Management System

Intervention Type BEHAVIORAL

Patients in this group use a printed asthma diary in their asthma self-management.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Mobile Asthma Management System

Patients in this group use a smartphone app in their asthma self-management.

Intervention Type BEHAVIORAL

traditional Asthma Management System

Patients in this group use a printed asthma diary in their asthma self-management.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1.18 years of age or older, having been resided in the same city during the study; 2.A history of at least 3 months of diagnosed asthma based on the criteria established by GINA 2016; need to be on medication containing ICS or ICS/LABA 3.Asthma out patients with ACT scores﹤20 and MARS - A mean score \< 4.5 ; 4.Owning and Being able to use smart phone that the corresponding software can be successfully installed; 5.Subjects who are willing to participate in the study and sign the informed consent.

Exclusion Criteria

1. Unable to communicate properly because of visual impairment, hearing impairment and language barrier, or with mental illness or psychological problems;
2. Have a history of tracheal intubation or mechanical ventilation as a result of acute asthma attack;
3. Have respiratory tract infection within the prior 4 weeks; history of thoracic surgery; with comorbidities such as other/structural lung diseases (COPD, bronchiectasis, lung cancer, et al); heart disease; kidney or autoimmunity disease; or other conditions that could potentially effect asthma control or asthma disease status by investigator's medical opinion.
4. Women with pregnancy, or planned pregnancy within one year.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No